English

Interim Report January – March 2014

Report this content

Summary of the period January – March 2014

  • Net turnover amounted to SEK 0 (0)
  • Profit after financial items amounted to KSEK -1 350 (-650)

Significant events during the period

  • The Company executed two share issues, one Private Placement in the amount of SEK 24,999,996 and one Rights Issue in the amount of SEK 10,410,295, Whereby the Company raised a little over SEK 35,000,000 prior to deducting the issue related expenses.
  • The share capital was increased by SEK 252,930.65 and currently amounts to SEK 847,804.70.
  • On March 14th trading of the Brighter share was transferred to NASDAQOMX First North from AktieTorget. The aim, which the Company achieved, was to broaden the ownership of the Company’s share and attract an international investor base.
  • During the period, the work to launch the product and achieve certification has elapsed as planned.

Financial calendar

Half-year report 2014: August 15th 2014
Report January – September 2014: November 14th 2014
Year-end Report 2014: February 20th 2015

Message from the CEO

The first quarter of 2014 has been very positive for Brighter since capital raised in the private placement and the rights issue has both given the company long term capital and new investors. The work to close the issues required considerable resources but despite this, the company could continue to develop the production launch - developing tools, etc. - and proceed with the certification as planned.

On a personal level it feels very positive to get proof, through interest of the investor community, that the Company and the staff are working toward the right goal - to help people with diabetes around the world with a better form of treatment.

In the second quarter, we continue to work to get the product into production, but we will also strengthen the organization with relevant expertise and dedication. On June 18th, we have scheduled our annual general shareholders meeting, during which we also intend to present and elect new board members - who each have relevant expertise and who have shown great interest in our company during the recruitment process.

Truls Sjöstedt
CEO Brighter AB (publ)

For further information, please contact:

Truls Sjöstedt, CEO
Telephone: +46 709 73 46 00
E-mail: truls.sjostedt@brightercompany.com

Henrik Norström, COO/Controller
Telephone: +46 733 40 30 45
E-mail: henrik.norstrom@brightercompany.com

Gert Westergren, Chairman of the Board
Telephone: + 46 705 55 77 99
E-mail: gert.westergren@brightercompany.com

  
About Brighter AB (publ)

Brighter One ™ – the patented all-in-one solution that combines the five things that millions of diabetics need to use several times every day to survive and feel well.

Brighter develops and commercializes innovative solutions for diabetes self-care. The Company's shares are listed on NASDAQOMX First North. More information is available at nasdaqomxnordic.com





Tags:

brighter

Documents & Links